BRIEF-Eiger Biopharmaceuticals Q4 loss per share $1.53
March 23, 2017 at 08:45 AM EDT
* Eiger biopharmaceuticals reports fourth quarter and full year 2016 financial results
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|